|
|
|
|
|
|
|
|
|
Monitoring patients at home using modern technology, so-called 'telehealth', is tipped as the next big thing in healthcare, but a new study by British researchers suggests it may not be worth the extra expense. The findings will fuel controversy over the economic case for telehealth, which many information technology and telecoms companies are betting on as a multibillion-dollar market opportunity. Antibiotics not worth risk in most chest colds Doctors need to give antibiotics to more than 12,000 people with acute respiratory infections to prevent just one of them from being hospitalised with pneumonia, according to a new study. And that small benefit is outweighed by the very real risks that go along with antibiotics - both from serious side effects and the promotion of resistant "superbugs", researchers say. Statins tied to lowered liver cancer risk with hepatitis C People infected with chronic hepatitis C are less likely to develop liver cancer if they are taking cholesterol-lowering drugs, a new research from Taiwan suggests. The report doesn't prove statins ward off cancer, and one researcher not involved in the study says it's not reason enough to recommend using the popular medications solely for liver cancer prevention. US paediatricians back gay marriage, adoption rights Gay and lesbian couples should be able to get married for the health and well-being of their children and families, the nation's leading group for paediatricians said in a policy statement that also backs adoption rights. The American Academy of Paediatrics, in calling on the legal right for same-sex couples to marry, said children's well-being is affected far more by other factors such as their parents' health and economic security than their sexual orientation. Study finds no constipation, colon cancer link Long-term constipation doesn't raise risk for colon and rectal cancers according to a new analysis of the existing evidence. Past studies had suggested a possible connection, but researchers said those results may have been skewed by poor study designs. — Agencies
|
||
|
|
||
As "telehealth"
grows, experts question cost benefits